| Application no. and date | 15838800.9 (espacenet) (Federated) (European Patent Register), 20150904 | | Patent/reg. no. and date | DK/EP 3188725, 20201028 | | Publication date | 20170712 | | Priority no. and date | SE 1451034, 20140904, SE 1550344, 20150324 | | EP pub. no. and date |
EP 3188725 20170712 | | Effective date | | | Applicant/owner | LobSor Pharmaceuticals Aktiebolag, Kålsängsgränd 10 D
753 19 Uppsala, SE | | Applicant ref. no. | P75395DK01 | | Inventor | BOLSÖY, Roger, Kolonivägen 16
741 44 Knivsta, SE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/165 (2006.01) , A61K 31/198 (2006.01) , A61K 31/277 (2006.01) , A61K 45/06 (2006.01) , A61K 47/38 (2006.01) , A61K 9/06 (2006.01) , A61P 25/16 (2006.01) | | Title | FARMACEUTISKE SAMMENSÆTNINGER OMFATTENDE LEVODOPA, EN DOPAMINDECARBOXYLASEINHIBITOR OG EN COMT-INHIBITOR OG FREMGANGSMÅDE TIL INDGIVELSE DERAF | | Int. application no. | SE2015050939 | | Int. publication no. | WO2016036308 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
